# China Depression Screening Mental Health Market > China Depression Screening Mental Health Market Research Report: Size, Share, Trend Analysis By Indication (Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, Others), By Diagnosis (Psychological Tests, Blood Tests, Pharmacogenomic Testing, Others) and By End Users (Hospitals and Clinics, Home-based, Research and Academic Institutes) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.87% - **2024:** $ 54.79 Million - **2025:** $ 58.01 Million - **2035:** $ 102.63 Million - **Key Players:** UnitedHealth Group (US), Anthem (US), Cigna (US), Kaiser Permanente (US), Teladoc Health (US), Mayo Clinic (US), HCA Healthcare (US), Cerner Corporation (US) **Report ID:** MRFR/HC/54524-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/china-depression-screening-mental-health-market-56290 --- ## Market Summary ## **China Depression Screening Mental Health Market Overview** As per MRFR analysis, the China Depression Screening Mental Health Market Size was estimated at 51.71 (USD Million) in 2024.The China Depression Screening Mental Health Market Industry is expected to grow from 54.75(USD Million) in 2025 to 110.9 (USD Million) by 2035. The China Depression Screening Mental Health Market CAGR (growth rate) is expected to be around 6.627% during the forecast period (2025 - 2035) **Key China Depression Screening Mental Health Market Trends Highlighted** The China Depression Screening Mental Health Market has seen significant trends reflecting the growing awareness and demand for mental health services. One of the key market drivers is the increasing incidence of depression and mental health disorders in China, driven by urbanization, high-pressure lifestyles, and social stigma surrounding mental health. The Chinese government has made mental health a priority in recent years, implementing guidelines and increasing funding for mental health services, contributing to the expansion of screening initiatives. Telehealth solutions are gaining popularity as a convenient alternative to traditional in-person consultations, allowing for wider access to screening tools, especially in rural areas where mental health resources are scarce. Opportunities within the market include the integration of technology into mental health screenings, such as mobile applications and AI-driven platforms. These digital solutions can provide immediate assessments, making screening more accessible and reducing the burden on healthcare professionals. Furthermore, partnerships between governmental bodies and private healthcare providers can enhance service delivery, leading to a more sensitive approach to mental health in Chinese communities. Recent trends indicate a shift towards preventive care, with mental health awareness campaigns aimed at educating the public on the importance of early diagnosis and treatment of depression. Organizations are increasingly focusing on destigmatizing mental health issues, which may encourage individuals to seek screening and support. Overall, the momentum in the China Depression Screening Mental Health Market highlights a collective movement towards improved mental health care services, increased accessibility, and technological advancements designed to support individuals in need of timely intervention. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **China Depression Screening Mental Health Market Drivers** **Increased Awareness of Mental Health Issues** In China, mental health awareness has significantly risen over the past decade due to various government initiatives and public health campaigns. The Chinese government has recognized mental health as a critical public health issue and has committed to improving mental health services, which include depression screening. According to recent surveys conducted by the National Health Commission, approximately 17% of the population suffers from mental disorders, with depressive disorders affecting about 6% of the population. The emphasis on mental health awareness in educational campaigns has profound implications for the China Depression Screening Mental Health Market Industry, as more individuals seek screening and treatment options. Established organizations like the China National Health Development Research Center have played a crucial role in this awareness increase, pushing for comprehensive mental health services to be integrated into public healthcare systems. **Government Policies Supporting Mental Health Services** The Chinese government has implemented several policies aimed at improving mental health services, particularly in urban areas where depression rates tend to be higher. The latest Mental Health Law promotes the establishment and improvement of mental health services, which includes mandates for depression screening. In a recent policy document, it was outlined that by 2025, the country aims to increase mental health service availability in communities by 30%. The change will impact the growth of the China Depression Screening Mental Health Market Industry. Institutions like the Chinese Academy of Sciences are engaged in R&D processes to improve screening methodologies and mental health outreach programs. **Rising Prevalence of Depression Amid Economic Changes** As China continues to undergo rapid economic changes, the prevalence of depression has risen among various demographic groups, notably in urban settings due to high-pressure lifestyles. The World Health Organization estimates that depression will be the leading cause of global health burden by 2030, with China being a key contributor due to its large population. A study published by the Chinese Journal of Psychiatry indicated that depressive symptoms increased by approximately 20% during the past decade, with significant demographic impacts observed among working-age adults. This alarming trend underlines the necessity for improved screening services, thereby driving the demand in the China Depression Screening Mental Health Market Industry. The active involvement of health organizations such as the Chinese Society of Psychiatry emphasizes the need for effective intervention strategies. **China Depression Screening Mental Health Market Segment Insights** **Depression Screening Mental Health Market Indication Insights** The China Depression Screening Mental Health Market focuses on various indications that play a critical role in mental health evaluation and treatment. Major Depressive Disorder is a prevalent condition that affects a significant portion of the population in China, leading to substantial societal implications, including increased healthcare costs and reduced productivity. Anxiety Distress is another common indication that often coexists with depressive disorders, making its identification critical for holistic mental health assessments. The increasing rates of chronic stress and societal pressures in urban areas contribute to the growing prevalence of anxiety-related issues, emphasizing the need for effective screening tools. Bipolar Disorder, characterized by extreme mood swings, is also gaining attention in China as awareness of mental health conditions continues to improve. With early detection being essential to managing the condition effectively, screening plays a vital part in facilitating timely interventions. Psychotic Disorders, though less common, pose significant challenges in mental health management and require timely identification to alleviate severe symptoms. This highlights the importance of comprehensive screening approaches across all indications, as varied mental health issues often intersect, affecting overall patient outcomes.The 'Others' category encompasses various emerging mental health disorders that are becoming more recognized, reflecting an evolving understanding of mental health needs in contemporary China.  Given that mental health is gaining increasing attention from both the government and society, the importance of addressing these specific indications cannot be overstated. The government has recognized the urgent need for mental health reforms, which are anticipated to bolster efforts in implementing effective screening practices throughout the country.Overall, understanding these indications is essential for improving the China Depression Screening Mental Health Market, ensuring that appropriate resources are allocated to meet the mental health needs of the population adequately. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Depression Screening Mental Health Market Diagnosis Insights** The Diagnosis segment of the China Depression Screening Mental Health Market plays a crucial role in identifying and addressing mental health disorders within the population. This segment includes various methods such as Psychological Tests, Blood Tests, and Pharmacogenomic Testing, each offering unique advantages in the screening process. Psychological Tests are significant as they facilitate the assessment of cognitive and emotional states, helping clinicians establish a comprehensive understanding of an individual's mental health. Blood Tests serve an essential function by allowing for the identification of potential biological markers associated with depression, contributing to a more tailored approach to treatment. Pharmacogenomic Testing is increasingly recognized for its importance in personalizing medication plans based on individual genetic profiles, enhancing the effectiveness of pharmacological interventions while minimizing adverse effects. Other diagnostic methods complement these primary approaches, broadening the toolkit available for effective depression screening in China. With rising awareness of mental health issues and the pressing need for efficient diagnosis, the momentum within the Diagnosis segment is expected to significantly influence the overall growth and improvement of mental health care services in the country. **Depression Screening Mental Health Market End User Insights** The China Depression Screening Mental Health Market is experiencing significant growth, with a notable focus on its End User segmentation which includes Hospitals and Clinics, Home-based, and Research and Academic Institutes. Hospitals and Clinics represent a major portion of the market, as they provide essential diagnostic and therapeutic services to patients seeking mental health care, thus serving as primary access points for depression screenings in China. Home-based care is gaining traction due to the increasing preference for convenient and personalized treatment options, especially in urban areas where the demand for mental health services is on the rise. This trend is being supported by the government's initiatives to improve mental health awareness and provide better resources for patients within their communities. Research and Academic Institutes play a crucial role in advancing methodologies and technologies for depression screening, contributing significantly to the development of effective treatment approaches and enhancing the overall understanding of mental health issues in China. These sectors collectively reflect the market's focus on improving accessibility, efficiency, and the overall quality of mental health services, aligning with broader healthcare reforms that stress the importance of mental health. **China Depression Screening Mental Health Market Key Players and Competitive Insights** The China Depression Screening Mental Health Market is witnessing substantial growth, driven by rising awareness of mental health issues and the increasing prevalence of depression among the population. As mental health has become a priority due to the psychological impacts of modern living, innovative screening methods and therapies are gaining traction. This market features numerous players ranging from established healthcare providers to emerging tech startups focused on mental health solutions. The competitive landscape is characterized by a mix of domestic and international companies that leverage cutting-edge technology, including digital tools and data analytics, to enhance diagnosis and treatment.  This dynamic environment is pushing organizations to collaborate, innovate, and differentiate their offerings in a rapidly evolving setting.Hongyun Medical stands out in the China Depression Screening Mental Health Market with its robust portfolio of services focused on diagnosing and treating mental health conditions. The company has developed user-friendly screening tools that have gained acceptance in both clinical settings and community health programs. Hongyun Medical's strengths lie in its strategic collaborations with healthcare institutions and emphasis on research and development that foster the introduction of reliable and efficient screening methods. Additionally, it has established a significant presence across various regions in China, allowing it to access a diverse population and tailor its offerings to meet specific regional needs.  This strong regional presence further solidifies its position in the competitive landscape, enabling better outreach and engagement with healthcare providers and patients alike.Psychemedics has made its mark within the China Depression Screening Mental Health Market through its pioneering analytic processes and comprehensive product offerings. The company's services revolve around advanced drug testing and analysis, which aids in better understanding the underlying factors contributing to depression. Psychemedics offers unique screening methodologies that are grounded in scientific research, positioning itself as a leader in the niche of mental health diagnostics.  The company's strengths include a strong network of partnerships with healthcare facilities and educational institutions across China, effectively contributing to its market presence. Furthermore, Psychemedics has been active in enhancing its portfolio through strategic mergers and acquisitions, allowing it to integrate new technologies and expand its service offerings. This strategic approach helps Psychemedics reinforce its influence in the Chinese market while continually addressing the evolving needs of mental health professionals and patients alike. **Key Companies in the China Depression Screening Mental Health Market Include** - Hongyun Medical - Psychemedics - Mindray - HC Medical - Beijing Yikang - Tianjin Yaojing - Zhejiang Huisheng - Chengdu Mindlight - DXY - Zhuoma Technology - Xiangyu Medical - Shanghai Liangxin - Witris - Shanghai Mental Health Center - Shenzhen Huayuan **China Depression Screening Mental Health Market Industry Developments** The China Depression Screening Mental Health Market has witnessed notable advancements recently. Significant emphasis is being placed on integrating technology into mental health solutions, with companies like Mindray and HC Medical enhancing their screening capabilities through innovative tools such as artificial intelligence. In September 2023, Hongyun Medical announced the launch of a new digital platform aimed at streamlining depression screenings across hospitals in China. Financially, the market is experiencing growth, with industry evaluations reaching approximately USD 2 billion, driven by increasing government initiatives to improve mental health services and the rising awareness of mental health issues among Chinese citizens.  Moreover, there have been essential mergers and acquisitions, such as the strategic partnership formed in August 2023 between Beijing Yikang and Chengdu Mindlight to strengthen their product offerings. Overall, the industry is evolving rapidly, with organizations like Zhuoma Technology and Xiangyu Medical exploring collaborative efforts to expand their reach in mental health services. Recent investments point towards a robust demand for accurate depression screening methods in response to the rising patient population across China. **China Depression Screening Mental Health Market Segmentation Insights** **Depression Screening Mental Health Market Indication****Outlook** - Major Depressive Disorder - Anxiety Distress - Bipolar Disorder - Psychotic Disorders - Others **Depression Screening Mental Health Market Diagnosis****Outlook** - Psychological Tests - Blood Tests - Pharmacogenomic Testing - Others **Depression Screening Mental Health Market End User****Outlook** - Hospitals and Clinics - Home-based - Research and Academic Institutes ## Market Drivers ### Rising Mental Health Awareness The increasing awareness of mental health issues in China is a crucial driver for the depression screening mental health market. Public campaigns and educational initiatives have contributed to a growing understanding of depression and its impact on individuals and society. As a result, more people are seeking screening and treatment options. According to recent surveys, approximately 16% of the Chinese population experiences depressive symptoms, highlighting the need for effective screening methods. This heightened awareness is likely to drive demand for mental health services, thereby expanding the market. Furthermore, the stigma surrounding mental health is gradually diminishing, encouraging individuals to seek help. The depression screening mental health market is poised to benefit from this cultural shift, as more individuals recognize the importance of mental well-being and actively pursue screening and treatment. ### Rising Prevalence of Depression Among Youth The rising prevalence of depression among the youth population in China is a critical driver for the depression screening market. Recent studies indicate that nearly 25% of adolescents report experiencing depressive symptoms, prompting a need for effective screening and intervention strategies. This demographic shift highlights the urgency for mental health services tailored to younger individuals. Schools and universities are increasingly recognizing the importance of mental health support, leading to the implementation of screening programs within educational institutions. As awareness grows and more young people seek help, the depression screening mental health market is likely to expand significantly. This trend underscores the necessity for targeted approaches to address the unique mental health challenges faced by the youth. ### Increased Funding for Mental Health Services The Chinese government has recognized the importance of mental health and is increasing funding for mental health services, which serves as a significant driver for the depression screening mental health market. In recent years, government expenditure on mental health has risen, with a focus on improving access to screening and treatment. Reports indicate that funding for mental health initiatives has increased by approximately 20% annually, reflecting a commitment to addressing mental health issues. This financial support enables the development of more comprehensive screening programs and the training of healthcare professionals. As a result, the depression screening mental health market is likely to expand, as more resources become available to facilitate early detection and intervention for depression. ### Technological Advancements in Screening Tools Technological innovations are transforming the landscape of the depression screening mental health market in China. The development of advanced screening tools, including mobile applications and online platforms, facilitates easier access to mental health assessments. These tools often utilize artificial intelligence and machine learning algorithms to provide accurate evaluations of depressive symptoms. As of 2025, it is estimated that over 30% of mental health screenings in urban areas are conducted through digital platforms. This trend not only enhances the efficiency of screening processes but also reaches a broader audience, particularly among younger populations who are more tech-savvy. The integration of technology into mental health services is likely to drive growth in the depression screening mental health market, as it offers convenient and timely access to necessary resources. ### Integration of Mental Health into Primary Care The integration of mental health services into primary care settings is emerging as a vital driver for the depression screening market in China. This approach allows for a more holistic view of patient health, where mental health screenings are conducted alongside physical health assessments. As of November 2025, approximately 40% of primary care facilities in urban areas are implementing mental health screening protocols. This integration not only improves access to mental health services but also encourages early detection of depressive symptoms. By normalizing mental health discussions within primary care, the stigma associated with seeking help is further reduced. Consequently, the depression screening mental health market is expected to grow as more individuals receive timely screenings and appropriate referrals for treatment. ## Future Outlook The [Depression Screening Mental Health Market](https://www.marketresearchfuture.com/reports/depression-screening-mental-health-market-3806) is projected to grow at a 5.87% CAGR from 2025 to 2035, driven by increasing awareness and technological advancements. **New opportunities:** - Development of AI-driven diagnostic tools for early detection. Expansion of telehealth services for remote patient monitoring. Integration of mental health screening in primary care settings. By 2035, the market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Indication: Major Depressive Disorder (Largest) vs. Anxiety Distress (Fastest-Growing) In the China depression screening-mental-health market, the market share distribution among the indication values shows that Major Depressive Disorder holds the largest share, reflecting the significant prevalence and recognition of this condition. In contrast, Anxiety Distress is showing a marked increase in share, indicating a shifting awareness and focus on this increasingly relevant mental health issue. Growth trends for these segments are driven by various factors, including an increasing willingness to seek professional help, the rising awareness of mental health issues among the public, and the growing number of private and public initiatives aimed at improving mental health services. With societal stigma reducing, more individuals are being diagnosed and treated, particularly in the segment of Anxiety Distress, which is gaining traction as a significant area of concern in mental health discussions. Major Depressive Disorder (Dominant) vs. Anxiety Distress (Emerging) Major Depressive Disorder remains the dominant segment in the China depression screening-mental-health market, characterized by a well-established diagnosis and treatment framework which attracts substantial funding and research. Patients within this category often require comprehensive, long-term management strategies that include psychotherapy and medication. Conversely, Anxiety Distress is emerging as a crucial segment, marked by a growing incidence rate and a rising demand for screening tools. The latter's rapid growth can be attributed to increased public awareness and changing societal attitudes towards mental health. Efforts to address this rising trend include expanding therapeutic options and integrating anxiety disorder screenings into primary healthcare systems. Both segments reflect the evolving landscape of mental health challenges in China. ### By Diagnosis: Psychological Tests (Largest) vs. Blood Tests (Fastest-Growing) In the China depression screening-mental-health market, Psychological Tests account for the largest share among various testing methods, showcasing their significance in diagnosing depression effectively. Blood Tests are rapidly gaining traction, although they currently represent a smaller market segment compared to Psychological Tests, indicating a shift towards a more diversified approach to mental health assessment. The growth trends in this sector reveal increasing adoption of advanced Psychological Tests driven by a greater understanding of mental health issues and improved healthcare policies focusing on mental wellbeing. Blood Tests are emerging as a promising alternative, accelerated by technological advancements that make these tests more accessible and efficient, thereby reshaping the traditional landscape of diagnostic methods in mental health. Psychological Tests: Dominant vs. Blood Tests: Emerging Psychological Tests hold a dominant position in the market, reflecting their established efficacy in diagnosing depression. These tests often involve standardized questionnaires that assess various psychological aspects, making them widely accepted among clinicians. On the other hand, Blood Tests represent an emerging market segment, appealing to both healthcare providers and patients looking for innovative solutions. They provide biochemical insights and could complement traditional methods, helping in more holistic patient assessments. The increasing awareness of mental health issues in society supports the growth of both segments, facilitating a broader array of options for diagnosis. ### By End User: Hospitals and Clinics (Largest) vs. Home-based (Fastest-Growing) In the China depression screening-mental-health market, the end user segment is predominantly led by hospitals and clinics, making up a significant share due to their established infrastructure and comprehensive services. Home-based solutions are rapidly gaining traction as more individuals seek accessible mental health resources from the comfort of their own environments. This shift is markedly influenced by the increasing awareness of mental health issues and the growing acceptance of telemedicine initiatives. The growth trends within this segment are driven by several factors, including a rise in mental health awareness and the stigma reduction surrounding mental health issues. Additionally, innovations in digital health technologies are promoting home-based screening, providing patients with flexibility and privacy. Research and academic institutes play a supportive role, contributing to evidence-based approaches that enhance service delivery across both dominant and emerging segments. Hospitals and Clinics (Dominant) vs. Home-based (Emerging) Hospitals and clinics hold a dominant position in the China depression screening-mental-health market, characterized by their comprehensive diagnostic facilities and access to trained mental health professionals. These institutions benefit from established trust and recognition in the community, often being the first point of contact for patients seeking help. In contrast, home-based solutions are emerging rapidly, facilitated by technological advancements that allow for remote screenings and consultations. This segment is particularly appealing to younger populations who value convenience and privacy, thus reshaping the traditional model of mental health services. As both segments evolve, the interplay between in-person and home-based solutions may redefine patient care strategies in the mental health landscape. ## Competitive Benchmarking The depression screening-mental-health market in China is characterized by a rapidly evolving competitive landscape, driven by increasing awareness of mental health issues and a growing demand for accessible screening solutions. Key players are strategically positioning themselves through innovation, partnerships, and digital transformation to capture market share. Notably, companies such as UnitedHealth Group (US), Cigna (US), and Teladoc Health (US) are focusing on enhancing their service offerings and expanding their reach within the region, thereby shaping a competitive environment that emphasizes both quality and accessibility of mental health services.In terms of business tactics, companies are increasingly localizing their operations to better cater to the unique needs of the Chinese market. This includes optimizing supply chains and leveraging local partnerships to enhance service delivery. The market appears moderately fragmented, with several key players exerting influence, yet the collective actions of these companies suggest a trend towards consolidation as they seek to enhance their competitive edge. In October UnitedHealth Group (US) announced a partnership with a leading Chinese telehealth provider to expand its mental health services, aiming to integrate advanced AI-driven screening tools into their platform. This strategic move is likely to enhance their service delivery and improve patient outcomes, reflecting a broader trend towards the integration of technology in mental health care. In September Cigna (US) launched a new initiative focused on mental health awareness and screening in urban areas of China, collaborating with local health authorities. This initiative not only aims to increase access to mental health resources but also positions Cigna as a proactive player in addressing mental health challenges, potentially leading to increased market penetration and brand loyalty. In August Teladoc Health (US) expanded its mental health services by acquiring a local mental health startup, which specializes in digital therapy solutions. This acquisition is indicative of a growing trend towards digitalization in mental health care, allowing Teladoc to enhance its service offerings and cater to a tech-savvy population seeking convenient mental health solutions. As of November the competitive trends in the depression screening-mental-health market are increasingly defined by digitalization, AI integration, and strategic alliances. Companies are moving towards a landscape where innovation and technology play pivotal roles in differentiation. The shift from price-based competition to a focus on quality, reliability, and technological advancement is evident, suggesting that future competitive dynamics will hinge on the ability to innovate and adapt to the evolving needs of consumers. ## Recent News & Developments The China Depression Screening Mental Health Market has witnessed notable advancements recently. Significant emphasis is being placed on integrating technology into mental health solutions, with companies like Mindray and HC Medical enhancing their screening capabilities through innovative tools such as artificial intelligence. In September 2023, Hongyun Medical announced the launch of a new digital platform aimed at streamlining depression screenings across hospitals in China. Financially, the market is experiencing growth, with industry evaluations reaching approximately USD 2 billion, driven by increasing government initiatives to improve mental health services and the rising awareness of mental health issues among Chinese citizens.  Moreover, there have been essential mergers and acquisitions, such as the strategic partnership formed in August 2023 between Beijing Yikang and Chengdu Mindlight to strengthen their product offerings. Overall, the industry is evolving rapidly, with organizations like Zhuoma Technology and Xiangyu Medical exploring collaborative efforts to expand their reach in mental health services. Recent investments point towards a robust demand for accurate depression screening methods in response to the rising patient population across China. ## Report Scope | MARKET SIZE 2024 | 54.79(USD Million) | | --- | --- | | MARKET SIZE 2025 | 58.01(USD Million) | | MARKET SIZE 2035 | 102.63(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.87% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | UnitedHealth Group (US), Anthem (US), Cigna (US), Kaiser Permanente (US), Teladoc Health (US), Mayo Clinic (US), HCA Healthcare (US), Cerner Corporation (US) | | Segments Covered | Indication, Diagnosis, End User | | Key Market Opportunities | Integration of digital health solutions enhances accessibility in the depression screening-mental-health market. | | Key Market Dynamics | Rising demand for digital mental health solutions drives innovation in depression screening methodologies and technologies. | | Countries Covered | China | ## Frequently Asked Questions **Q: What was the market valuation of the China depression screening-mental-health market in 2024?** A: The market valuation was $54.79 Million in 2024. **Q: What is the projected market valuation for the China depression screening-mental-health market by 2035?** A: The projected valuation for 2035 is $102.63 Million. **Q: What is the expected CAGR for the China depression screening-mental-health market during the forecast period 2025 - 2035?** A: The expected CAGR is 5.87% during the forecast period 2025 - 2035. **Q: Which key players are leading the China depression screening-mental-health market?** A: Key players include UnitedHealth Group, Anthem, Cigna, Kaiser Permanente, Teladoc Health, Mayo Clinic, HCA Healthcare, and Cerner Corporation. **Q: What are the major segments of the China depression screening-mental-health market?** A: Major segments include Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, and Others. **Q: What was the market size for Major Depressive Disorder in 2024?** A: The market size for Major Depressive Disorder was $20.0 Million in 2024. **Q: What is the projected market size for Psychological Tests by 2035?** A: The projected market size for Psychological Tests is expected to reach $38.0 Million by 2035. **Q: How does the market size for Home-based services compare to Hospitals and Clinics in 2024?** A: In 2024, Home-based services had a market size of $15.0 Million, while Hospitals and Clinics reached $20.0 Million. **Q: What is the expected growth for Pharmacogenomic Testing in the China depression screening-mental-health market?** A: Pharmacogenomic Testing is projected to grow from $5.0 Million in 2024 to $10.0 Million by 2035. **Q: What are the anticipated trends in the end-user segment of the China depression screening-mental-health market?** A: The end-user segment is expected to show growth, particularly in Research and Academic Institutes, which had a market size of $19.79 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-depression-screening-mental-health-market-56290*